SOLICITATION NOTICE
A -- Biologically-derived Medicines on Demand - DARPA-BAA-11-71
- Notice Date
- 8/30/2011
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Other Defense Agencies, Defense Advanced Research Projects Agency, Contracts Management Office, 3701 North Fairfax Drive, Arlington, Virginia, 22203-1714
- ZIP Code
- 22203-1714
- Solicitation Number
- DARPA-BAA-11-71
- Archive Date
- 12/15/2011
- Point of Contact
- Geoffrey Ling,
- E-Mail Address
-
DARPA-BAA-11-71@darpa.mil
(DARPA-BAA-11-71@darpa.mil)
- Small Business Set-Aside
- N/A
- Description
- DARPA-BAA-11-71 The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs. See Attached DARPA-BAA-11-71.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/ODA/DARPA/CMO/DARPA-BAA-11-71/listing.html)
- Record
- SN02556507-W 20110901/110831001029-5690e6a033e320b5aec2cb7510072cfa (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |